Expression of the H19 Oncofetal Gene in Premalignant Lesions of Cervical Cancer: A Potential Targeting Approach for Development of Nonsurgical Treatment of High-Risk Lesions

Table 1

The level of H19 RNA transcript in samples obtained from patients diagnosed with CIN 3 determined by ISH analysis.

Patient number	Intensity	Area
1	++	+++
2	++	+
3	+++	+++
4	++	+++
5	+++	+++
6	+++	+++
7	+++	+++
8	+	+
9	+++	+++
10	−	−

∗Areas of surrounding normal cervical epithelium did not stain for H19 by ISH in all 10 samples.